| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.1872 | 49 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.2521 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.7564 | 48 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.2477 | 46 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.294 | 49 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.675 | 53 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 54.1855 | 58 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.1259 | 56 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 51.0991 | 52 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.9674 | 48 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.4442 | 57 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.0708 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.8516 | 44 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.1902 | 49 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 51.5796 | 53 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.275 | 42 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.8522 | 44 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.105 | 52 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.458 | 53 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.7023 | 53 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.1501 | 49 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.1603 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.5047 | 50 |